{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-001640","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2025-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.782189+00:00","generated_at":"2026-05-28T08:50:05.554832+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Unicycive gets Nasdaq extension to July 7, 2025 to meet $1 bid price","bullets":["Initial non-compliance notice received July 9, 2024; 180-day cure period ended Jan 6 without compliance.","Nasdaq granted an additional 180 calendar days, until July 7, 2025, to regain $1.00 minimum bid.","Company will monitor bid price and may consider options such as a reverse stock split if needed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-001640","json":"https://secwatch.observer/filing/0001213900-25-001640.json","markdown":"https://secwatch.observer/filing/0001213900-25-001640.md","text":"https://secwatch.observer/filing/0001213900-25-001640.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025001640/0001213900-25-001640-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025001640/ea0227071-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T08:50:05.554832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}